Back to search
FDAFDA · Food and drugs·Recall number D-0692-2017

Aripiprazole Tablets, 2 mg, 30 count unit dose box, Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada, Distributed by Major Pharmaceuticals, Livonia, MI NDC 0904-6509-04

Published May 10, 2017 · Recall initiated: December 27, 2016

Summary

FDA records drug Class III recall D-0692-2017, published May 10, 2017 and initiated December 27, 2016. Recalling firm: The Harvard Drug Group; Status: Terminated; Reported quantity: 36,990 tablets; Lot: LOT: T-00601 Exp: 04-2017. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent Drug; out of specification results for assay (manufacturer)

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
The Harvard Drug Group
Distributor
Nationwide and PR
Lot
LOT: T-00601 Exp: 04-2017
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Aripiprazole Tablets, 2 mg, 30 count unit dose box, Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada, Distributed by Major Pharmaceuticals, Livonia, MI NDC 0904-6509-04 recalled?

Yes. FDA published recall D-0692-2017 on May 10, 2017. Reported hazard: Superpotent Drug; out of specification results for assay (manufacturer)

What should I do if I have this product?

Voluntary: Firm initiated · Letter